Member Info for Steadydanny

SOG. HI. Steady here.
I'm joining some dots. Please correct if wrong.
REGN COV2 currently being studied in two phasec3/3 clinical trials.

I quote ...partnering with healthcare laboratories, ........and organizational

Evaluated 1000s of fully human antibodies produced by the companys proprietary Veloclimmune mice

Roche website ...date 19th August...our last update RNS 19TH August....total radio silence since..

Please read it as I greatly appreciate your opinion. Do you think this has been the tie up and silence.

I will read more. Hope I haven't got the wrong end of the stick. But they mention they have been partnering .......
Best regards Steadydanny

Pme rns 436pm

Spot on Star. This has got very intriguing. Seems to be a plethora of pharmas delivering RNSs today. I suspect some of them are about partnerships between themselves.
Further investors will see this as a great entry point. Tick tock ....

Hi mafuta.
I'm really intrigued by the last RNS. They have been dealing with AZ(we know about them re SO) and are discussing new licencees or raise. I'm wondering if we see some subscriptions appear here as an alternative investment strategy.
I'm still getting my head around this but I'm thinking early doors.
Best wishes Steadydanny

Im pretty excited about this.

I'm following RENX RNS re how government officiated boards respond. But that's my opinion.

I agree. The Times report today re Jisc and Alibaba link up re security issues on oversea students having concerns has seen this go further south. Just look at the spread! This is going to implode.

A few have mafuta ;-) tick tock

That is definitely interesting .

Many thanks James. Greatly appreciate. I might add that charts on AIM are not easy. Seen fundamentals get a kick with an out of the blue RNS. I personally don't see that here. Imo. But who the f**k knows!
But I do enjoy reading responses re posts and responses that are put as a discussion point yet get a slight derogatory response, and wonder if some have an affiliation with the board (maybe conference catchup and discussons pre covid restrictions)and have a more knowledgeable awareness.
I'm well aware of AIM and sticking to my guns on how some post.

I'm assuming they are buys. James any thoughts appreciated.
Re 737 still two conferences Sierra are booked into. Last being the 28th. 3 days prior to Q4.
Save the best to last? The 'fireside chat' sounds like one of those cosy conversations over a wee dram and maybe a subtle hint might be slightly speculative but camouflaged?
Sometimes it's what isn't being said is the loudest not to be heard.
Fingers crossed.

Afham. Just look at the FT report re GSK being wiped off the floor by AZ! It was around May I believe.
They have turned the tables.
Not having a pop at you by any means but just pointing this out.

Addendum. Alan Sugar is a Baron.

Just to add re sirreas upcoming 3 conferences the last is on the 28th September. 3 days prior to Q4! And it is reported as a 'fireside chat' starting at 4pm ET.
I read recently that in tax claims for work undertaken that 'fireside chats' was reported as a means that Sir Alan Sugar claimed tax back.
I'm just putting it out there but if you had something noteable who would you want at the negotiating table or atleast known to be an investor by potential buyers and on our side?
Personally I'd be 'honoured'.
Bwdik.
Best regards Steadydanny

Are partaking in one of three upcoming conferences starting tomorrow at the 23rd HC Wainwright Conference to update on its position and future progressions.
Given the AZ link up earlier with Sierra and a recent report a certain Israeli doctor re wanting to further his early research into a nebuliser covid treatment in stopping the cytokone storms affecting the lungs of some patients, and advises he is in discussions ....'with several American companies but it would be great to explore the possibility of working with Astra Zeneca'.
AZ declined to comment.
Just wondered if anyone might have any thoughts as to if Sierra mention 737 and as has been proported before the Sierra and AZ link up and pound to a penny they would have undertaken indepth dd with Sierra and their partners and their partners ipr (all of it!) both on an ethical and scientific basis.
So I'm going to guess we get a late RNS tomorrow or early Tuesday re our ceo following up Sierras participation in the first of 3 closely dated conferences.
Regards Steadydanny

Completely agree Lazarus. And what HNWIs would want to be associated with investing in a company which came post the Edison report to see a negative outcome? I'm sure they did dd. They and Edison would not look good in regards to future investment advice and their continuity , and i'm sure the board were selective in who they let invest onto our ipr. Not flippers but proper investors.

Make that 2 pmes....hmmm

We are in a pme.....

Unite. You would do well to read the RNSs re research updates and trials. So far so good. But a couple hoops ahead and competitors. But imo any company involved in kinase inhibitors is going to do well. You need to do a bit more research re timelines and ongoing research. Heads up.....we got 4.5m for research going forward.
Best wishes Steadydanny

Scirroco Energy are part of a webinar on 21st September.
Be interesting to hear their opinion on how they stand with money raised via selling He1 shares, which they reininvested into themselves, not long before our price 'drop'.
I wonder if they have been quietly adding He1 shares since and discuss their neighbours potential and progress.
Food for thought.
I'm holding and suspect we see a rise imminently. We have spoil knowledge from the drills. That's all some discovery companies do without a sound knowledge of what Oxford University provided re Helium potential given the geology. So if initial drills are not what was hoped we have drill info that 'other' companies might find useful.
Got a good feeling here.
Ps Bunsa if you read this, the fair was a great success but wombles and spoons don't mix ;-). Local vets undertaking spoon removal met an all time high :-)
Just my thoughts.